A patient with myeloma who still has pure red cell aplasia despite the most intensive immune modulation.
Orchard
J
J
Department of Haematology, Royal Bournemouth Hospital, U.K.
Myint
H
H
Hamblin
T J
TJ
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D001803:Blood Transfusion; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000150:complications*; D012010:Red-Cell Aplasia, Pure / Q000150:complications* / Q000276:immunology / Q000628:therapy
D000276:Adjuvants, Immunologic